Literature DB >> 8380082

A single point mutation in the VP7 major core protein of bluetongue virus prevents the formation of core-like particles.

H Le Blois1, P Roy.   

Abstract

To understand the assembly process of bluetongue virus (BTV), we have established a functional assay which allows us to produce and manipulate BTV core-like particles (CLPs) composed of the viral VP7 and VP3 proteins. A cDNA clone encoding the 349-amino-acid VP7 protein has been manipulated to generate deletion, extension, and site-specific mutants. Each mutant was coexpressed with the BTV VP3 protein to generate CLPs. Deletion and extension mutants involving the VP7 carboxy terminus prevented CLP formation, while an extension mutant involving an 11-amino-acid rabies virus sequence added to the amino terminus of VP7 allowed CLP formation. Substitution of either of two cysteine residues of VP7 (Cys-15 or Cys-65) by serine also did not prevent CLP formation; however, substitution of the single lysine residue of VP7 (Lys-255) by leucine abrogated CLP formation, indicating a critical role for this lysine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380082      PMCID: PMC237370     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Three-dimensional structure of single-shelled bluetongue virus.

Authors:  B V Prasad; S Yamaguchi; P Roy
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Bluetongue virus evolution: sequence analyses of the genomic S1 segments and major core protein VP7.

Authors:  T F Kowalik; J K Li
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

3.  Mapping of two immunodominant antigenic epitopes conserved among the major inner capsid protein, VP7 of five bluetongue viruses.

Authors:  J K Li; Y Y Yang
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

4.  Complete nucleotide sequence of segment 5 of epizootic haemorrhagic disease virus; the outer capsid protein VP5 is homologous to the VP5 protein of bluetongue virus.

Authors:  H Iwata; T Hirasawa; P Roy
Journal:  Virus Res       Date:  1991-08       Impact factor: 3.303

5.  Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins.

Authors:  T J French; J J Marshall; P Roy
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

6.  A bluetongue serogroup-reactive epitope in the amino terminal half of the major core protein VP7 is accessible on the surface of bluetongue virus particles.

Authors:  B T Eaton; A R Gould; A D Hyatt; B E Coupar; J C Martyn; J R White
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

7.  Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like proteins.

Authors:  P T Loudon; P Roy
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

8.  Characterization of the genes encoding two of the major capsid proteins of epizootic haemorrhagic disease virus indicates a close genetic relationship to bluetongue virus.

Authors:  H Iwata; T Chuma; P Roy
Journal:  J Gen Virol       Date:  1992-04       Impact factor: 3.891

9.  Synthesis and characterization of chimeric particles between epizootic hemorrhagic disease virus and bluetongue virus: functional domains are conserved on the VP3 protein.

Authors:  H Le Blois; B Fayard; T Urakawa; P Roy
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

10.  Three-dimensional reconstruction of baculovirus expressed bluetongue virus core-like particles by cryo-electron microscopy.

Authors:  E A Hewat; T F Booth; P T Loudon; P Roy
Journal:  Virology       Date:  1992-07       Impact factor: 3.616

View more
  8 in total

1.  Intermolecular interactions in a two-layered viral capsid that requires a complex symmetry mismatch.

Authors:  Chang-Kwang Limn; Polly Roy
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

2.  Preparation and Characterization of a Monoclonal Antibody Against the Core Protein VP7 of the 25th Serotype of Bluetongue Virus.

Authors:  Xiao Wu; Qi Liu; Jia He; Mingxin Zang; Haixiu Wang; Yijing Li; Lijie Tang
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-04

3.  Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells.

Authors:  S E Crawford; M Labbé; J Cohen; M H Burroughs; Y J Zhou; M K Estes
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

4.  Functional dissection of the major structural protein of bluetongue virus: identification of key residues within VP7 essential for capsid assembly.

Authors:  C K Limn; N Staeuber; K Monastyrskaya; P Gouet; P Roy
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Crystal structure of the top domain of African horse sickness virus VP7: comparisons with bluetongue virus VP7.

Authors:  A K Basak; P Gouet; J Grimes; P Roy; D Stuart
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Rearrangement of the VP6 gene of a group A rotavirus in combination with a point mutation affecting trimer stability.

Authors:  S Shen; B Burke; U Desselberger
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 7.  Virus-like particles: models for assembly studies and foreign epitope carriers.

Authors:  Andrzej Palucha; Adrianna Loniewska; Subbian Satheshkumar; Anna M Boguszewska-Chachulska; Mahadevaiah Umashankar; Malgorzata Milner; Anne-Lise Haenni; Handanahal Subbarao Savithri
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

Review 8.  Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance.

Authors:  Luis Jiménez-Cabello; Sergio Utrilla-Trigo; Natalia Barreiro-Piñeiro; Tomás Pose-Boirazian; José Martínez-Costas; Alejandro Marín-López; Javier Ortego
Journal:  Vaccines (Basel)       Date:  2022-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.